Summary
Updated Aug 30, 2026
Leslie J. Williams is Director of OCULAR THERAPEUTIX, INC (OCUL). 1 SEC Form 4 filing on record, dated 12 June 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Leslie J. Williams has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Leslie J. Williams files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Pravin Dugel - $1.94M of OCUL open-market activity in the last 12 months
- Richard L. Md Lindstrom - $461K of OCUL open-market activity in the last 12 months
- Namrata Saroj - $278K of OCUL open-market activity in the last 12 months
- Jeffrey S. Heier - $243K of OCUL open-market activity in the last 12 months
- Peter Kaiser - $223K of OCUL open-market activity in the last 12 months
- Nadia Waheed - $221K of OCUL open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Leslie J. Williams?
Leslie J. Williams is a corporate insider, tracked as Director of OCULAR THERAPEUTIX, INC (OCUL). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Leslie J. Williams submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Leslie J. Williams's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Leslie J. Williams and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
